Analyst forecasts YoY quarterly growth for Coloplast following virus year

Improved market conditions owing to increased patient access in the wake of societal reopenings should, says Denmark's Sydbank, result in Coloplast reporting growth on Wednesday, when the Danish medical tech firm presents its Q3 interim report for fiscal 2021.
Photo: Coloplast / PR
Photo: Coloplast / PR

Upon presenting its third-quarter statement for staggered fiscal year 2020-'21, Danish medical technology company Coloplast is expected to announce growth driven by improved market conditions tied to improved patient access following societies opening back up from pandemic lockdowns, says Senior Analyst Søren Løntoft Hansen from Denmark's Sydbank.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading